Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 14, Issue 2, Pages 477-480Publisher
WILEY
DOI: 10.1111/ajt.12577
Keywords
Clostridium difficile; fecal microbiota transplantation; fecal transplant; lung transplant; renal transplant; solid organ transplant
Categories
Funding
- CSK-NIH/NCRR [KL2 TR000455, UL1TR000454]
Ask authors/readers for more resources
Fecal microbiota transplantation (FMT) has been shown to be safe and efficacious in individuals with refractory Clostridium difficile. It has not been widely studied in individuals with immunosuppression due to concerns about infectious complications. We describe two solid organ transplant recipients, one lung and one renal, in this case report that both had resolution of their diarrhea caused by C. difficile after FMT. Both recipients required two FMTs to achieve resolution of their symptoms and neither had infectious complications. Immunosuppressed individuals are at high risk for acquisition of C. difficile and close monitoring for infectious complications after FMT is necessary, but should not preclude its use in patients with refractory disease due to C. difficile. Sequential FMT may be used to achieve cure in these patients with damaged microbiota from antibiotic use and immunosuppression. The authors describe two solid organ transplant recipients who underwent fecal microbiota transplantation for multiply recurrent C. difficile infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available